ATE433571T1 - Methode zur diagnose von nierenerkrankungen - Google Patents
Methode zur diagnose von nierenerkrankungenInfo
- Publication number
- ATE433571T1 ATE433571T1 AT02775280T AT02775280T ATE433571T1 AT E433571 T1 ATE433571 T1 AT E433571T1 AT 02775280 T AT02775280 T AT 02775280T AT 02775280 T AT02775280 T AT 02775280T AT E433571 T1 ATE433571 T1 AT E433571T1
- Authority
- AT
- Austria
- Prior art keywords
- cystatin
- concentration
- kit
- creatinine
- antibody
- Prior art date
Links
- 208000017169 kidney disease Diseases 0.000 title abstract 4
- 102000012192 Cystatin C Human genes 0.000 abstract 10
- 108010061642 Cystatin C Proteins 0.000 abstract 10
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 abstract 10
- 229940109239 creatinine Drugs 0.000 abstract 5
- 238000005259 measurement Methods 0.000 abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 230000002485 urinary effect Effects 0.000 abstract 2
- 210000002700 urine Anatomy 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000012790 confirmation Methods 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 238000006911 enzymatic reaction Methods 0.000 abstract 1
- 230000001434 glomerular Effects 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001306445 | 2001-10-02 | ||
| PCT/JP2002/010233 WO2003031967A1 (fr) | 2001-10-02 | 2002-10-01 | Kits de diagnostic de maladies renales |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE433571T1 true ATE433571T1 (de) | 2009-06-15 |
Family
ID=19126083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02775280T ATE433571T1 (de) | 2001-10-02 | 2002-10-01 | Methode zur diagnose von nierenerkrankungen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040241774A1 (de) |
| EP (1) | EP1437591B1 (de) |
| AT (1) | ATE433571T1 (de) |
| DE (1) | DE60232595D1 (de) |
| WO (1) | WO2003031967A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008092214A1 (en) * | 2007-02-02 | 2008-08-07 | Minomic International Limited | Biomarkers for diabetes |
| ES2532221T3 (es) * | 2007-03-26 | 2015-03-25 | Novartis Ag | Biomarcadores de seguridad renal predictiva y señales de biomarcadores para monitorizar la función renal |
| CA2682543A1 (en) * | 2007-03-26 | 2008-10-02 | The University Of Chicago | Immunoassays and characterization of biomolecular interactions using self- assembled monolayers |
| KR100882471B1 (ko) | 2007-06-22 | 2009-02-09 | 고려대학교 산학협력단 | 당뇨병성 신증 진단용 바이오 마커 조성물 |
| RU2348038C1 (ru) * | 2007-06-26 | 2009-02-27 | Государственное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко Федерального агентства по здравоохранению и социальному развитию" | Способ диагностики диабетической нефропатии на доклинической стадии |
| WO2010145880A1 (en) * | 2009-04-30 | 2010-12-23 | Roche Diagnostics Gmbh | Means and methods for diagnosing a diabetes mellitus associated kidney damage in individuals in need of a suitable therapy |
| CA3067107C (en) | 2010-06-03 | 2022-07-12 | Idexx Laboratories, Inc. | Markers for renal disease |
| NZ606186A (en) * | 2010-06-24 | 2015-02-27 | Murray Goulburn Coop Co Ltd | Use of lactoferrin to treat proteinuria |
| CN102590497B (zh) * | 2012-01-13 | 2014-01-01 | 宁波美康生物科技股份有限公司 | 胱氨酸蛋白酶抑制剂c检测试剂盒 |
| CN103018465A (zh) * | 2012-12-16 | 2013-04-03 | 北京利德曼生化股份有限公司 | 一种人胱抑素c化学发光定量检测方法 |
| JP6196034B2 (ja) | 2012-12-20 | 2017-09-13 | ライオン株式会社 | 高血糖リスク判定用マーカーペプチドおよびその用途 |
| CN105388298A (zh) * | 2015-10-30 | 2016-03-09 | 山东博科生物产业有限公司 | 一种胱抑素c纳米胶乳免疫比浊法检测试剂盒 |
| EP3665705B1 (de) | 2017-08-08 | 2024-12-18 | Fresenius Medical Care Holdings, Inc. | Systeme und verfahren zur behandlung und schätzung des fortschreitens einer chronischen nierenerkrankung |
| CN109613256A (zh) * | 2018-11-21 | 2019-04-12 | 杭州康知生物科技有限公司 | 尿四种微量蛋白定量联检荧光免疫层析试剂盒及制备方法 |
| SE2430014A1 (en) * | 2024-01-18 | 2025-05-27 | P & M Venge Ab | Urinary biomarker of kidney function |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5733787A (en) * | 1996-06-17 | 1998-03-31 | Bayer Corporation | Method for the detection of creatinine |
| JP3342819B2 (ja) * | 1997-08-20 | 2002-11-11 | 株式会社いかがく | 腎症の早期診断用キット |
| JP2000193662A (ja) * | 1998-12-25 | 2000-07-14 | Tomakomai Rinsho Kensa Center:Kk | 尿中シスタチンｃ測定試薬及び診断方法並びにキット |
-
2002
- 2002-10-01 WO PCT/JP2002/010233 patent/WO2003031967A1/ja not_active Ceased
- 2002-10-01 US US10/489,923 patent/US20040241774A1/en not_active Abandoned
- 2002-10-01 EP EP02775280A patent/EP1437591B1/de not_active Expired - Lifetime
- 2002-10-01 DE DE60232595T patent/DE60232595D1/de not_active Expired - Lifetime
- 2002-10-01 AT AT02775280T patent/ATE433571T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60232595D1 (de) | 2009-07-23 |
| EP1437591A4 (de) | 2006-05-10 |
| EP1437591B1 (de) | 2009-06-10 |
| US20040241774A1 (en) | 2004-12-02 |
| EP1437591A1 (de) | 2004-07-14 |
| WO2003031967A1 (fr) | 2003-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bökenkamp et al. | Reference values for cystatin C serum concentrations in children | |
| ATE433571T1 (de) | Methode zur diagnose von nierenerkrankungen | |
| Koppe et al. | Performance of creatinine-based equations compared in older patients. | |
| Skurup et al. | New creatinine sensor for point-of-care testing of creatinine meets the National Kidney Disease Education Program guidelines. | |
| Jung et al. | Urinary enzymes and low-molecular-mass proteins as indicators of diabetic nephropathy. | |
| Newman | Cystatin c | |
| RU2262706C2 (ru) | Способ для диагностики атрофических гастритов | |
| Mojiminiyi et al. | Evaluation of cystatin C and β-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus | |
| Weinert et al. | Gender does not influence cystatin C concentrations in healthy volunteers | |
| WO2002027326A3 (en) | Method and kit for the transderaml determination of analyte concentration in blood | |
| Maeda et al. | Urinary albumin and transferrin as early diagnostic markers of chronic kidney disease | |
| TW200641352A (en) | Oxidizable species as an internal reference in control solutions for biosensors | |
| ATE438860T1 (de) | P1gf und flt-1 als prognostische parameter bei kardiovaskulären erkrankungen | |
| CN104198473A (zh) | 一种稳定的尿酸检测试剂盒 | |
| NO20050186L (no) | Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser | |
| RU2019143570A (ru) | Диагностика периодонтита на основании hgf и mmp-8 в слюне | |
| Puhakainen et al. | An automated colorimetric assay for urine nicotine metabolites: a suitable alternative to cotinine assays for the assessment of smoking status | |
| Piwowar et al. | Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy | |
| RU2008103988A (ru) | Способ диагностики рассеяного склероза | |
| WO2002057793A3 (en) | Method of detecting prp protein and kits therefor | |
| US5776780A (en) | Method for quantitatively measuring white blood cells esterase activity in urine | |
| Abuşoğlu et al. | A short guideline on chronic kidney disease for medical laboratory practice | |
| US20090011431A1 (en) | Diagnosis of Sepsis by the Selective Determination of the Concentration of Cu/Zn Superoxide Dismutase (Cu/Zn Sod) in Patient Samples | |
| ATE261120T1 (de) | Anhand der konduktivität normalisierte bestimmung von analyten in urin zur diagnose von krankheiten | |
| WO2001071024A1 (fr) | Procede de dosage de l'albumine glyquee |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |